GT Biopharma Q4 EPS $(4.84) Down From $(1.66) YoY
Benzinga Newsdesk 8 months ago
EarningsNews
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(4.84) per share. This is a 191.57 percent decrease over losses of $(1.66) per share from the same period last year.
GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(4.84) per share. This is a 191.57 percent decrease over losses of $(1.66) per share from the same period last year.